Results 71 to 80 of about 7,896 (176)

SÍNDROME DE RECONSTITUIÇÃO IMUNE: UM OBSTÁCULO EM POTENCIAL NO MANEJO DO SARCOMA DE KAPOSI EM PACIENTES HIV POSITIVOS? – RELATO DE CASO

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2014
A diversidade de apresentações clínicas da síndrome de reconstituição imune faz da mesma um desafio clínico, na medida em que é difícil o manejo de infecções oportunistas e outras condições clínicas relacionadas com tal síndrome.
Felipe Ladeira de Oliveira   +7 more
doaj   +1 more source

Overview on Epstein–Barr Virus–Host Interactions With a Focus on Host Cell Transcriptome Alterations

open access: yesCell Biochemistry and Function, Volume 44, Issue 10, October 2026.
ABSTRACT The Epstein–Barr virus (EBV) belongs to the gamma subgroup of human herpesviruses. EBV is particularly lymphotropic regarding its latency, meaning that it preferentially targets lymphocytes as its immunological niche. During the establishment of the complex virus–host relationships, the virus influences the human host cell transcriptome ...
Louise Wallot   +5 more
wiley   +1 more source

Sarcoma de Kaposi en trasplante renal, respuesta a sirolimus: reporte de caso y revisión de la literatura científica

open access: yesRevista Universitas Medica, 2011
El cáncer en el paciente que ha recibido un trasplante es una enfermedad reconocida, con factores de riesgo demostrados e incidencia 3,12 mayor que en la población general.
PAOLA KARINA GARCÍA   +5 more
doaj  

Posttranslational Modifications of p62/SQSTM1 in Health and Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Schematic illustration of p62 as a posttranslational modifications (PTMs)‐programmed integrator in homeostasis, pathogenesis, and therapeutic targeting. (Left) Homeostasis: In physiological states, p62, through various PTMs such as phosphorylation, ubiquitination, and acetylation, coordinates essential cellular functions.
Weikai Wang   +8 more
wiley   +1 more source

ALGUNAS CONSIDERACIONES SOBRE EL SARCOMA DE KAPOSI BUCAL EPIDÉMICO

open access: yesArchivo Médico de Camagüey, 2007
El sarcoma de Kaposi era un raro tumor antes de la infección por el virus de inmunodeficiencia humana cuando se hizo común, se considera una neoplasia compuesta por elementos vasculares y fibroblásticos.
Oscar N. García Roco Pérez   +3 more
doaj  

Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.

open access: yesPLoS Pathogens, 2007
Kaposi sarcoma is a tumor consisting of Kaposi sarcoma herpesvirus (KSHV)-infected tumor cells that express endothelial cell (EC) markers and viral genes like v-cyclin, vFLIP, and LANA.
Sonja Koopal   +10 more
doaj   +1 more source

Glutamine Metabolism in Health and Diseases

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Glutamine metabolism acts as a metabolic hub connecting cellular stress adaptation, immune regulation, and disease development. Through regulating energy production, biosynthesis, redox balance, and nitrogen metabolism, glutamine supports cellular homeostasis under physiological and pathological conditions.
Yi Ding   +3 more
wiley   +1 more source

Pseudosarcoma de Kaposi tipo Mali unilateral en paciente con insuficiencia venosa crónica

open access: yesRevista Habanera de Ciencias Médicas, 2020
Introducción: La insuficiencia venosa crónica es el conjunto de síntomas y signos derivados de una hipertensión venosa en los miembros inferiores debido a un mal funcionamiento valvular de los sistemas venosos.
Mabel González Escudero   +2 more
doaj  

Sarcoma de Kaposi asociado a corticoterapia sistémica

open access: yesActas Dermo-Sifiliográficas, 2007
Resumen El sarcoma de Kaposi (SK) fue descrito por Moritz Kaposi en 1872. Las caracteristicas epidemiologicas del SK apuntan a una probable causa infecciosa. Se han identificado fragmentos de ADN que corresponden a un virus herpes no identificado previamente, el virus herpes humano tipo 8, en biopsias de SK asociado a sida.
B. González-Sixto   +5 more
openaire   +1 more source

Outcomes of Kaposi sarcoma in people living with HIV who maintain long‐term viral suppression: A prospective case‐series

open access: yesHIV Medicine, Volume 27, Issue 10, Page 1715-1721, October 2026.
Abstract Background Data on chemotherapeutic efficacy and tolerability for Kaposi Sarcomas (KS) in people living with HIV (PWH) and HIV‐virological control are limited. We aimed to describe clinical responses and tolerability of KS therapies in PWH with HIV‐aviraemic KS in a prospective cohort.
S. Bacquart   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy